JY
BCAB icon

Jeff Yass’s BioAtla BCAB Stock Holding History

Jeff Yass’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-264
Closed -$7.79K – 12472
2024
Q4 		$7.79K Buy
+264
New +$22.2K ﹤0.01% 11995
2023
Q2 		– Sell
-532
Closed -$71.3K – 12057
2023
Q1 		$71.3K Sell
532
-900
-63% -$162K ﹤0.01% 11521
2022
Q4 		$591K Buy
1,432
+160
+13% +$66.4K ﹤0.01% 7418
2022
Q3 		$490K Buy
1,272
+842
+196% +$276K ﹤0.01% 8545
2022
Q2 		$61K Sell
430
-1,076
-71% -$171K ﹤0.01% 11853
2022
Q1 		$377K Buy
+1,506
New +$630K ﹤0.01% 9689

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's BCAB Position: Q2 2026 in Review

Jeff Yass sold out of BioAtla (BCAB) in Q2 2026, closing a stake of 781 shares — an estimated $6.29K sold.

Jeff Yass first reported a position in BCAB in Q2 2021 and held it in 20 quarters. The position peaked at $1.88M in Q4 2022. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Jeff Yass reported no remaining BioAtla position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 781 BioAtla shares in Q2 2026, an estimated $6.29K.
  • Jeff Yass first reported a position in BioAtla in Q2 2021 and held it in 20 quarters.
  • Jeff Yass's BioAtla position peaked at $1.88M in Q4 2022.
  • 21 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.